J&J ordered to pay $417M in trial over talc cancer risks

Health Care Reuters

A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake - RTSX61S

Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.

Continue Reading Below

The Los Angeles Superior Court jury's verdict in favor of California resident Eva Echeverria was the largest to date in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of talc-based products.

More from FOXBusiness.com...

The verdict was confirmed by a spokeswoman for Echeverria's lawyers. J&J said it will appeal. 

(Reporting by Nate Raymond in Boston; Editing by Matthew Lewis)

What do you think?

Click the button below to comment on this article.